During the past decade, Saint Joseph Mercy Port Huron conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 43 clinical trials were completed, i.e. on average, 1433.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 8 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Joseph Mercy Port Huron" #1 sponsor was "National Cancer Institute (NCI)" with 29 trials, followed by "Alliance for Clinical Trials in Oncology" with 6 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored, "SWOG Cancer Research Network" with 5 trials sponsored and "Gynecologic Oncology Group" with 5 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Joseph Mercy Port Huron" #1 collaborator was "National Cancer Institute (NCI)" with 24 trials as a collaborator, "NRG Oncology" with 9 trials as a collaborator, "Eastern Cooperative Oncology Group" with 3 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator and "NCIC Clinical Trials Group" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Saint Joseph Mercy Port Huron" are "Recurrent Non-small Cell Lung Cancer" (4 trials), "Stage IV Ovarian Cancer" (4 trials), "Ovarian Clear Cell Cystadenocarcinoma" (3 trials), "Ovarian Endometrioid Adenocarcinoma" (3 trials) and "Recurrent Cervical Carcinoma" (3 trials). Many other conditions were trialed in "Saint Joseph Mercy Port Huron" in a lesser frequency.

Most popular intervention types in "Saint Joseph Mercy Port Huron" are "Drug" (49 trials), "Other" (24 trials), "Biological" (18 trials), "Procedure" (4 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (11 trials), "Paclitaxel" (8 trials), "Carboplatin" (7 trials), "Bevacizumab" (6 trials) and "bevacizumab" (5 trials). Other intervention names were less common.

The vast majority of trials in "Saint Joseph Mercy Port Huron" are 34 trials for "All" genders, 15 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Joseph Mercy Port Huron". undefined are not yet recruiting, undefined are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 34 completed trials in Saint Joseph Mercy Port Huron, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Joseph Mercy Port Huron, 2 "Phase 1" clinical trials were conducted, 32 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".